Sep 07, 2017 12:30 pm UTC| Business
HAYWARD, Calif., Sept. 07, 2017 -- Anthera Pharmaceuticals, Inc. (Nasdaq:ANTH) today announced that the screening for the RESULT Phase 3 clinical study has surpassed the halfway mark. RESULT is studying the use of a...
Sep 07, 2017 12:30 pm UTC| Business
BOTHELL, Wash., Sept. 07, 2017 -- Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a clinical-stage biopharmaceutical company developing monoclonal antibody therapeutics, today announced that eptinezumab, the company’s...
Rockwell Medical Appoints John G. Cooper to Board of Directors
Sep 07, 2017 12:30 pm UTC| Business
WIXOM, Mich., Sept. 07, 2017 -- Rockwell Medical, Inc. (NASDAQ:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products for...
Airgain to Present at the 6th Annual Liolios Gateway Conference Today, September 7, 2017
Sep 07, 2017 12:30 pm UTC| Business
SAN DIEGO, Sept. 07, 2017 -- Airgain, Inc. (NASDAQ:AIRG), a leading provider of advanced antenna technologies used to enable high performance wireless networking, has been invited to present at the 6th Annual Liolios...
Giggles N Hugs’ Announces Common Stock Rights Offering in S-1 Filing
Sep 07, 2017 12:30 pm UTC| Business
Los Angeles, Sept. 07, 2017 -- Giggles N’ Hugs Inc. (OTCQB:GIGL) (the “Company”) owner and operator of family-friendly restaurants that bring together high-end, organic food with active play and entertainment for...
Sep 07, 2017 12:30 pm UTC| Business
CARLSBAD, Calif., Sept. 07, 2017 -- International Stem Cell Corporation (OTCQB:ISCO), a California-based clinical stage biotechnology company developing stem cell-based therapies and biomedical products, today reported...
Wabash National’s Acquisition of Supreme Clears Antitrust Review
Sep 07, 2017 12:30 pm UTC| Business
LAFAYETTE, Ind., Sept. 07, 2017 -- Wabash National Corporation (NYSE:WNC) today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, or HSR Act, applicable to the acquisition...